An interventional study of Mulligan Mobilization with movement MWM and Kinesiotaping in Knee Injuries, Sport Injury and Knee Injuries, sponsored by University Aleksander Moisiu Durres. Completed at 1 site in Albania. Open to participants aged 14 Years to 22 Years. Per ClinicalTrials.gov, last updated 2026-04-03.
Sponsored by University Aleksander Moisiu Durres · Not applicable, Interventional, and Treatment
This is a randomized RTC study where the KOS-ADLS score of athletes' functionality and the OSTRC score of sports overuse injuries were used as outcomes, which were measured before the start of treatment, 1 hour and 2 weeks after treatment. In this study, 3 forms of intervention were used: Mulligan, Kinesiotaping and placebo in young basketball players with knee injuries.
Study type: Randomized Clinical Trial RTC ,with three intervention groups. Population: young basketball players. The intervention will last 2 weeks. Outcomes: KOS-ADLS; OSTRC. Statistical analysis: Mixed ANOVA
Male and female basketball players Minimum of 2 years of sports experience Presence of knee injury Active participation in organized sports
Exclusion Criteria:
Previous knee surgery Knee instability Neurological disorders Refusal or contraindication to Mulligan mobilization
Participants received MWM in the squot position with tibial glide by a physiotherapist licensed to apply the Mulligan technique. 2 times a week for 2 weeks with a duration of 5min.
Other: Mulligan Mobilization with movement MWM
Participants in the kinesiotaping group were applied the same kinesiotaping pattern regardless of injury type, with a frequency of 2 times a week for 2 weeks.
Other: Kinesiotaping
Placebo participants underwent a sham intervention to mimic the treatment without therapeutic effect twice a week for 2 weeks for 5 minutes.
Other: Placebo
Participants received the MWM technique in a squat position with a tibial glide by a physiotherapist certified in the mulligan concept twice a week for 2 weeks, the treatment lasted 5 minutes.
Participants received the same kinesiotaping pattern regardless of injury type twice a week for 2 weeks for 5 minutes.
Participants received a sham intervention to mimic the treatment without therapeutic effect twice a week for 2 weeks, lasting 5 minutes.
KOS-SAS (ADLS)
The Activities of Daily Living Scale (ADLS) subscale of the Knee Outcome Survey evaluates symptoms and functional limitations during daily activities. Scores range from 0 to 100, with higher scores indicating better function.
Time frame: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention
Overuse Injury Questionnaire - Oslo Sports Trauma Research Center (OSTRC)
The Oslo Sports Trauma Research Center (OSTRC) Overuse Injury Questionnaire is a validated self-report instrument used to monitor the severity and impact of overuse-related musculoskeletal problems. It evaluates the consequences of knee-related problems on sports participation, training volume, sports performance, and symptom severity. Responses to the four key questions are converted into a severity score ranging from 0 to 100, where higher scores indicate greater symptom severity and functional impairment.
Time frame: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention
Sports Activity Scale (SAS) - Knee Outcome Survey.
The Sports Activity Scale (SAS) of the Knee Outcome Survey assesses knee symptoms and functional limitations during sports and higher-level activities. The scale ranges from 0 to 100, with higher scores indicating better sports-related knee function.
Time frame: Baseline (Day 0), 1 hour after intervention, and 2 weeks after intervention
Documents are hosted by the registry — open the source record to download them.
Plan to share: No — The individual participant data (IPD) from this study will not be shared due to ethical and privacy considerations. The study involves minor athletes (under 18 years old), and participant consent does not include data sharing with external researchers. To ensure confidentiality and comply with ethical approvals, the data will remain restricted to the study investigators.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.